Aimago announces first deliveries to the US

Please login or
register
29.10.2012

Last October Aimago announced that it got FDA Clearance of its perfusion camera. The first cameras were delivered to the US.

Aïmago SA, a Swiss medical device company, announces the first deliveries of its cameras to the US. The tablet-based Aïmago EasyLDI greatly simplifies perfusion assessment; already CE-marked, it is in active use in several leading European plastic & reconstructive surgery, burn care and wound healing centers.

Aïmago’s EasyLDI provides surgeons and nurses with a highly intuitive, non-invasive, repeatable and user-independent diagnostic imaging tool to objectively identify poorly perfused tissue. This clinically relevant information empowers surgeons to reduce the risk of skin necrosis and delayed healing, thereby leading to better and earlier decision-making for a range of surgical procedures.

Aïmago is a privately held, investor-backed medical device company founded in 2008 as a spin-off from the EPFL (Swiss Federal Institute of Technology in Lausanne) and specializing in perfusion assessment in various clinical settings. Aïmago’s revolutionary EasyLDI microcirculation camera enjoys significant patent protection, is already in use at several hospitals in the EU, and is slated for launch in the US in 2012. The company has won several awards, including the CTI MedTech Award 2011 from the Swiss government and the W.A. de Vigier Award for best Swiss start-up.

0Comments

More news about

aïmago

rss